Drug Type Fusion protein |
Synonyms tTF-NGR (University of Muenster) |
Target |
Mechanism APN inhibitors(Aminopeptidase N inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoma | Phase 1 | - | - | |
Neoplasms | Preclinical | DE | 01 Mar 2008 |
Phase 1 | 24 | jnhflnmxnj(rdcvuqvqaw) = qhktgpduzo gvgfzkpzqj (gfhlzrqioh, maijbfzmpi - xrrwjpeudv) View more | - | 08 Dec 2020 | |||
Phase 1 | 17 | wccvyarwsa(awbhoaozje) = Isolated Troponin T hs elevation occurred as DLT and was interpreted as sensitive early sign for myocardial cell hypoxia, valuable for prevention of clinically relevant side effects. ofoyoydtek (rayohaojia ) View more | - | 17 Sep 2020 | |||
Phase 1 | 17 | kuofmtqubb(pawzgvcfkm) = solated and reversible elevation of high sensitivity (hs) Troponin T hs without clinical sequelae qodsaxbvcg (wedvfrurgc ) View more | Positive | 07 Jun 2020 |